GHO Capital-led consortium, including the management and investors: Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, completed the acquisition of a majority stake in Envision Pharma, an international, innovative global technology and scientific communication company, from private equity firm Ardian. Financial terms were not disclosed. "Having worked alongside GHO for 4 years, we are delighted they have chosen to extend and deepen the partnership in a new investment cycle. We see a clear commitment to expanding our reach across the healthcare services spectrum, most notably in medical affairs, with the ultimate goal of enhancing physicians’ abilities to improve patient outcomes," David Thompson, Envision CEO.